skip to content

Cambridge Immunology Network

 

Helen Lee (Haematology) was selected from 470 nominations by the European Patent Office to be one of the 3 finalists for SAMBA, the technology she and her group have developed. They have greatly simplified the detection of infectious diseases by nucleic acid amplification suitable for resource-poor settings.

Helen Lee (Haematology) was selected from 470 nominations by the European Patent Office to be one of the 3 finalists for SAMBA, the technology she and her group have developed. They have greatly simplified the detection of infectious diseases by nucleic acid amplification suitable for resource-poor settings. Below is a link to the interview the European Patent Office made with Helen, where you can see the technology in action.
 
There is a prize by popular vote and if you would like to show your support for this worthy cause, please use the following link which takes less than a minute to do. The  voting has already started and will end May 31. You can vote once per day everyday until the deadline: